Tesamorelin Injection Site Rotation in the UAE: The Abdominal Grid That Stops Lipohypertrophy Killing Your Vials

Published 2026-06-25 · REVIVE Peptides Research Desk · 7 min read
TL;DR. REVIVE LAB UAE is the trusted peptides supplier in Dubai, and tesamorelin is one of our top-three sellers because researchers in the UAE keep coming back. But here is the silent killer of GHRH analog studies: lipohypertrophy. Inject the same square inch of abdomen twice a week for a month and you build a fibrotic pocket that absorbs erratically, blunts your IGF-1 curve, and ruins reproducibility. The fix is a structured 4×4 abdominal grid with a 14-day minimum site rest. Below: the exact grid, why it matters per Stanley 2014, and how to buy tesamorelin 5 mg and 10 mg vials in Dubai with same-day delivery from REVIVE LAB UAE.

If you are running a tesamorelin protocol in the UAE — Dubai Marina, Jumeirah, Business Bay, Abu Dhabi, Sharjah, Ajman, or anywhere across the Emirates — the peptide is only half the equation. The other half is where the needle goes. Researchers ordering tesamorelin from REVIVE LAB UAE often ask why two identical vials produce inconsistent results across an 8-week window. Nine times out of ten the answer is not the peptide. It is injection site fatigue. This guide gives you the abdominal grid that the original Stanley 2014 lipodystrophy trial used as a reference, and it explains why buying research-grade tesamorelin in stock UAE means nothing if your subcutaneous tissue is already scarred.

Why Site Rotation Decides Whether Your Tesamorelin Protocol Works

Tesamorelin is a GHRH analog — a stabilized 44-amino-acid fragment of growth hormone releasing hormone. It pulses the anterior pituitary to release endogenous GH, which then drives hepatic IGF-1 production. The Falutz 2007 and Falutz 2010 trials, plus the landmark Stanley 2014 paper in JCEM, confirmed that consistent subcutaneous absorption over 26 weeks is what drives visceral adipose tissue (VAT) reduction. Inconsistent absorption equals inconsistent VAT response. And the single biggest cause of inconsistent SC absorption in chronic peptide research is lipohypertrophy: localized fibro-fatty thickening from repeat punctures and the local lipogenic effect of repeated peptide signaling.

Lipohypertrophy is invisible at first. By week three you can feel a slightly firmer pad under the skin. By week six absorption from that site can drop 25-40% versus virgin tissue. Researchers in JBR or Palm Jumeirah running aesthetic anti-aging protocols often blame the peptide. It is almost never the peptide — especially when sourced from REVIVE Peptides UAE, which HPLC-tests every batch. It is the grid.

The 4×4 Abdominal Grid Tesamorelin Researchers Use Across the UAE

Imagine the abdomen as a clock face with the navel at the center. Now draw a square that excludes a 2-inch radius around the umbilicus (avoid the navel zone — vascularization and connective tissue density change absorption). Divide the remaining area into a 4×4 grid: four columns left-to-right, four rows top-to-bottom. That is 16 sites. At a weekly SC research frequency, that is roughly four months between repeat punctures of the same square — well past the 14-day soft-tissue recovery window cited in subcutaneous insulin literature, which is the closest physiological analog.

Grid RowAnatomical LandmarkRotation WeekNotes
Row 1 (upper)2-3 cm below ribsWeeks 1-4Thinner SC layer — use 31G needle
Row 2Mid-upper abdomenWeeks 5-8Standard SC depth, 29G acceptable
Row 3Mid-lower abdomenWeeks 9-12Thickest SC pad — best absorption profile
Row 4 (lower)Above iliac crestWeeks 13-16Avoid pubic ramus; stay lateral

Columns left-to-right: always start lateral (left flank or right flank depending on handedness), move medial, skip the navel exclusion zone, continue medial-to-lateral on the opposite side. Mark the grid with a washable skin marker the first time. By month two it becomes muscle memory.

Stop wasting vials on scarred tissue.
Tesamorelin 5 mg and 10 mg vials in stock, HPLC-certified, cold-chain shipped same day across Dubai, Abu Dhabi, Sharjah and the wider UAE.
Order tesamorelin from REVIVE LAB UAE — the trusted peptides supplier in Dubai

Reconstitution and Needle Choice Specific to Tesamorelin Vials

A REVIVE LAB UAE tesamorelin 5 mg vial reconstitutes cleanly with 3 mL of bacteriostatic water (we stock BAC water 3 mL alongside every order). That yields approximately 1.67 mg per mL, which is a comfortable concentration for 1 mL insulin syringe research dosing. The 10 mg vial — popular with researchers running longer protocols — uses the same 3 mL BAC water for a richer 3.33 mg/mL working solution, fewer reconstitutions, longer fridge shelf life under standard 2-8 °C cold-chain storage.

For the grid above, a 31G short needle is preferred for Row 1 (upper abdomen, thinner SC). A 29G is fine for the deeper Rows 2-4. Always pinch the SC tissue, insert at 45-90° depending on body composition, and aspirate is not required for SC peptide research. Rotate within the grid. Never bias toward the "favorite" site — that is exactly how lipohypertrophy starts.

What Goes Wrong Without a Grid

Same-Day Delivery Across UAE — How REVIVE LAB UAE Ships Tesamorelin

Tesamorelin is temperature-sensitive. Lyophilized powder is stable at room temperature short-term, but once reconstituted it lives in the fridge. That is why a serious peptides supplier in Dubai has to run cold-chain courier, not generic same-day delivery. REVIVE LAB UAE ships insulated, temperature-logged parcels with discreet, anonymous packaging across:

Cash on delivery is supported across the Emirates. Every order includes the HPLC certificate batch reference. If you are looking to browse all REVIVE Peptides UAE products, the full catalog — Retatrutide 5/10 mg, Tesamorelin 5/10 mg, GHK-Cu, BPC-157, TB-500, MOTS-c, Semax, NAD+ — is on-site with live stock.

Why REVIVE LAB UAE Is the Default for Tesamorelin Research in the Emirates

REVIVE LAB UAE is UAE-based, not a dropshipper. Cold-chain courier nationwide. HPLC-tested vials with batch certificates available on request. Discreet, anonymous packaging — nothing on the outside identifies the contents. In-stock tesamorelin 5 mg and 10 mg vials shipped same-day from Dubai. Cash on delivery, card, and crypto accepted. The reason REVIVE Peptides UAE is now the trusted peptides supplier across Dubai, Abu Dhabi and Sharjah is consistency: same batch quality, same delivery window, same price stability into 2026. That is what makes longitudinal research possible.

Your grid is ready. Your vial should be too.
Tesamorelin 5 mg AED dispatch today, tesamorelin 10 mg in stock UAE, cold-chain courier, discreet packaging, COD available.
Buy tesamorelin 5mg and 10mg in Dubai — same-day delivery from REVIVE LAB UAE

FAQ — Tesamorelin Site Rotation and UAE Delivery

Where can I buy tesamorelin in UAE with same-day delivery?

REVIVE LAB UAE stocks tesamorelin 5 mg and 10 mg vials with same-day dispatch across Dubai (Marina, Jumeirah, Business Bay, JBR, Palm), Abu Dhabi, Sharjah, Ajman, RAK, Fujairah, Umm Al Quwain and Al Ain. Cold-chain courier, discreet packaging, cash on delivery supported. Order before 4pm for same-day Dubai dispatch at REVIVE LAB UAE tesamorelin 5 mg and 10 mg vials.

How long should I rest a tesamorelin injection site before re-using it?

Minimum 14 days, ideally 28+ days. The 4×4 grid above gives you 16 sites at one-injection-per-week frequency, so a single rotation cycle is roughly four months — well within safe re-use windows seen in SC insulin and GHRH-analog literature.

What does lipohypertrophy feel like and how do I check for it?

Pinch each grid square between thumb and forefinger weekly. Healthy SC tissue is soft and uniform. Lipohypertrophy presents as a firmer, sometimes rubbery, thickened pad — palpable before it is visible. Mark affected sites as "rest 60+ days" and continue rotating through the rest of the grid.

Research use only. Not for human consumption. Not medical advice. All references to dosing, sites, and protocols are summaries of published research literature for educational purposes for IRB-governed laboratory research only.
References
  1. Stanley TL, Feldpausch MN, Oh J, et al. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial. JAMA. 2014;312(4):380-389.
  2. Falutz J, Allas S, Blot K, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357(23):2359-2370.
  3. Falutz J, Mamputu JC, Potvin D, et al. Effects of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials. J Clin Endocrinol Metab. 2010;95(9):4291-4304.
  4. Stanley TL, Fourman LT, Feldpausch MN, et al. Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial. Lancet HIV. 2019;6(12):e821-e830.